首页 | 本学科首页   官方微博 | 高级检索  
     

香菇多糖和顺铂胸腔注射对肺癌术后胸腔积液患者的临床疗效比较
引用本文:吴智宁,王文祥,张百华,肖琦,阳鹏,周明,喻巍. 香菇多糖和顺铂胸腔注射对肺癌术后胸腔积液患者的临床疗效比较[J]. 肿瘤药学, 2014, 0(6): 446-449
作者姓名:吴智宁  王文祥  张百华  肖琦  阳鹏  周明  喻巍
作者单位:湖南省肿瘤医院/中南大学湘雅医学院附属肿瘤医院胸外二科,湖南长沙410013
基金项目:中南大学湘雅医学院附属肿瘤医院青年基金项目资助(P2013-02)。
摘    要:
目的:探讨香菇多糖和顺铂胸腔注射对肺癌术后胸腔积液患者的临床疗效及生活质量的影响。方法选取我院肺癌术后合并胸腔积液的患者60名,随机分为香菇多糖组与顺铂组,各30例,两组患者均采用胸腔置管闭式引流术,其中香菇多糖组给予香菇多糖8 mg胸腔内注射,顺铂组给予顺铂40 mg胸腔内注射,每周1次,共3次。比较两组患者治疗期间的临床疗效、不良反应,并评价两组患者的生活质量。结果香菇多糖组临床有效率为63.3%,与顺铂组比较,差异无统计学意义(P〉0.05);香菇多糖组生活质量缓解率为86.7%,明显高于顺铂组的50%,而不良反应发生率显著低于顺铂组,差异均有统计学意义(P〈0.05)。结论使用香菇多糖胸腔注射治疗恶性胸腔积液,具有疗效肯定,不良反应发生率低,提升患者生活质量的明显优势。

关 键 词:香菇多糖  肺癌  胸腔积液

Comparison of the Effects of Lentinan and Cisplatin on the Postoperative Lung Cancer Patients with Pleural Effusion
WU Zhining,WANG Wenxiang,ZHANG Baihua,XIAO Qi,YANG Peng,ZHOU Ming,YU Wei. Comparison of the Effects of Lentinan and Cisplatin on the Postoperative Lung Cancer Patients with Pleural Effusion[J]. Anti-Tumor Pharmacy, 2014, 0(6): 446-449
Authors:WU Zhining  WANG Wenxiang  ZHANG Baihua  XIAO Qi  YANG Peng  ZHOU Ming  YU Wei
Affiliation:(Thoracic Surgery Department 2, Hunan Cancer Hospital & the Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, Hunan, 410013, China)
Abstract:
Objective To investigate the curative effects of lentinan and cisplatin intrapleural injection in the treatment of postoperative lung cancer patients with pleural effusion. Methods Sixty postoperative lung cancer patients with pleural ef-fusion were selected from our hospital and divided into lentinan group (30 patients) and cisplatin group (30 patients). Both of the two groups were treated with closed drainage, followed by intrapleural injection of lentinan 8 mg for the lentinan group, cisplatin 40 mg for the cisplatin group, once a week, three times. After treatment, the effects and adverse reactions were com-pared between the two groups, and the quality of the life improvement rate was evaluated. Results The clinical efficiency of the lentinan group was 63.3%, which has no significant difference with the cisplatin group (P〉0.05). In the lentinan group, 86.7%patients had their quality of life improved, while 50%in the cisplatin group did. The lentinan group had a higher improvement rate than the cisplatin group (P〈0.05). The adverse effects rate of the lentinan group was significant lower than that of the cisplatin (P〈0.05). Conclusion The intrapleural injection of lentinan had definite clinical effect, lower adverse reaction inci-dence and improved quality of life for postoperative lung cancer patients with pleural effusion.
Keywords:Lentinan Cisplatin Lung cancer Pleural effusion
本文献已被 维普 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号